Abstract
The Canadian Association of Pediatric Health Centres, working in partnership with the Public Health Agency of Canada has recently published a toolkit to guide screening for identification of risk of FAS/FASD. One of the tools highlighted is the testing of meconium for fatty acid ethyl esters to identify high risk pregnancies and to support associated prevention programs. This paper describes the conclusions of a workshop held in Prince Edward Island in September 2011 to discuss key issues surrounding the wider deployment of meconium testing for assessment of population risk for FAS/FASD.
| Original language | English |
|---|---|
| Pages (from-to) | e500-502 |
| Journal | Journal of Population Therapeutics and Clinical Pharmacology |
| Volume | 18 |
| Issue number | 3 |
| State | Published - 2011 |